Ethylamine

Ethylamine

SCHEMBL4431062

CCN.c1cc2cc-2n1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL4819184 0.87
SCHEMBL632201 0.84
Methyl Alcohol SCHEMBL21630012 0.82
Ammonia Solution, Strong SCHEMBL28823448 0.82
Ethylene SCHEMBL28883508 0.79
SCHEMBL10913951 0.76 MAP4K4 (0.43)
SCHEMBL16390982 0.75
Acetic Acid SCHEMBL9941297 0.74 KMO (0.47)
Boric Acid SCHEMBL8755222 0.73 HSD17B1 (0.40)
Pyridine SCHEMBL102868 0.71 ASIC3 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012485-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-01-10 US disclosed
EP-2124913-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS Novartis AG (CH) 2009-12-02 EP disclosed
WO-2008077597-A1 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS NOVARTIS AG (CH) 2008-07-03 WO disclosed